In This Article:
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and alongside that, an expanding base of capital employed. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. So when we looked at iHuman (NYSE:IH) and its trend of ROCE, we really liked what we saw.
Return On Capital Employed (ROCE): What Is It?
For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. The formula for this calculation on iHuman is:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
0.11 = CN¥99m ÷ (CN¥1.4b - CN¥449m) (Based on the trailing twelve months to June 2024).
Thus, iHuman has an ROCE of 11%. In absolute terms, that's a pretty normal return, and it's somewhat close to the Entertainment industry average of 10%.
View our latest analysis for iHuman
While the past is not representative of the future, it can be helpful to know how a company has performed historically, which is why we have this chart above. If you'd like to look at how iHuman has performed in the past in other metrics, you can view this free graph of iHuman's past earnings, revenue and cash flow.
What Does the ROCE Trend For iHuman Tell Us?
Investors would be pleased with what's happening at iHuman. Over the last four years, returns on capital employed have risen substantially to 11%. The company is effectively making more money per dollar of capital used, and it's worth noting that the amount of capital has increased too, by 2,398%. This can indicate that there's plenty of opportunities to invest capital internally and at ever higher rates, a combination that's common among multi-baggers.
In another part of our analysis, we noticed that the company's ratio of current liabilities to total assets decreased to 33%, which broadly means the business is relying less on its suppliers or short-term creditors to fund its operations. This tells us that iHuman has grown its returns without a reliance on increasing their current liabilities, which we're very happy with.
In Conclusion...
To sum it up, iHuman has proven it can reinvest in the business and generate higher returns on that capital employed, which is terrific. And since the stock has fallen 37% over the last three years, there might be an opportunity here. With that in mind, we believe the promising trends warrant this stock for further investigation.